Jersey Shore Multiple Sclerosis Center

Neptune, New Jersey

Academic MS Center
5 Active TrialsInfusion CenterVirtual CareMedium Practice
11 MS centers statewide · Ranked #4 in New Jersey for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health System

You’re looking at an academic MS center that brings neurology, therapy, psychology, and infusion care together in one program. You’ll likely appreciate the breadth of services, the on-site infusion therapy, and the option for virtual visits.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care4/5

About Jersey Shore Multiple Sclerosis Center

This center combines academic MS expertise with a broad specialty team and on-site infusion therapy. It also has fellowship training in multiple sclerosis.

Jersey Shore Multiple Sclerosis Center treats multiple sclerosis as well as related conditions such as optic neuritis, transverse myelitis, neuromyelitis optica spectrum disorders, and acute disseminated encephalomyelitis. Patients can access medical evaluation, infusion therapy, rehabilitation services, neuropsychology, pain management, and support for bladder, bowel, sexual, vision, sleep, and swallowing concerns. The center also offers diagnostic testing such as blood work, spinal tap, imaging studies, motor function assessment, and neuropsychological assessments. Its team approach and academic setting make it a strong option for people who want coordinated specialty MS care in one place.

Jersey Shore Multiple Sclerosis Center is an academic MS center in Neptune, New Jersey, based at Jersey Shore University Medical Center. You receive care from a multidisciplinary team that includes neurologists, MS nurse practitioners, infusion nurses, therapists, psychologists, and research coordinators. The center is part of Hackensack Meridian Health and the Hackensack Meridian Neuroscience Institute. It also offers on-site infusion therapy and virtual visits, so care can be delivered in more than one way.

Featured Care Team Members

Lana Zhovtis Ryerson, MD
Program Director of Neuroimmunology; Research Director for Neuroscience; Fellowship Director for Multiple Sclerosis
Neuroimmunology / multiple sclerosis
Maya Madhavan, MD
Neuroimmunology / multiple sclerosis
Amos Katz, MD
Neuroimmunology / multiple sclerosis
Patricia Mezzina, APN
Neurology

Specialized Programs

Neuroimmunology
Research and clinical trials
Rehabilitation services

Services & Treatments

What They Treat
Multiple sclerosisAcute disseminated encephalomyelitisNeuromyelitis optica spectrum disordersOptic neuritisTransverse myelitis
How They Treat It
Medical evaluationBotox injectionsGait assessmentBaclofen pump managementInfusion therapyPhysical therapyNeuropsychologyHealth psychologyClinical trialsBladder, bowel and sexual dysfunction managementPain managementOccupational therapySpeech therapySwallow therapyVision servicesSpecialty sleep servicesBotoxBaclofen pumpInfusion therapyLemtradaNovantroneOcrevusTysabriAvonexBetaseronCopaxoneAubagioGilenyaTecfideraTrigger point injectionsNerve blocks
Diagnostics
Blood workSpinal tapImaging studiesMotor function assessmentNeuropsychological assessments

Research & Clinical Trials

This center is currently involved in 5 clinical trials — ranked #4 in New Jersey for active trials

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE4
OfatumumabDisease modifying treatment (DMT)
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Hoffmann-La Roche
RECRUITING
MS Care Platform (icobrain ms and icompanion ms)

Insurance & Access

Contact
1945 State Route 33, Neptune, NJ 07753
Insurance & Support

FAQs from Jersey Shore Multiple Sclerosis Center

The center treats multiple sclerosis and related neuroinflammatory conditions, including acute disseminated encephalomyelitis, neuromyelitis optica spectrum disorders, optic neuritis, and transverse myelitis.

Yes. The center has on-site infusion therapy, and several MS treatments are part of the program, including Ocrevus, Tysabri, Lemtrada, Novantrone, Avonex, Betaseron, Copaxone, Aubagio, Gilenya, and Tecfidera.

The center offers blood work, spinal tap, imaging studies, motor function assessment, and neuropsychological assessments as part of MS care.

Yes. Services include physical therapy, occupational therapy, speech therapy, swallow therapy, gait assessment, pain management, bladder and bowel care, sexual dysfunction management, vision services, and specialty sleep services.

You can call 732-897-3620 to schedule an appointment. The center also offers virtual visits, which may make access easier for some patients.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website